Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Tuesday, March 28, 2017

Allergan plc a leading global pharmaceutical company and Paratek Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry announced that two 2 Phase 3 trials of sarecycline for the treatment of moderate..

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Tuesday, March 28, 2017

Orexigen Therapeutics Inc announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd and Bruno Farmaceutici SpA Bruno have executed a distributorship agreement for Mysimba naltrexone HCl bupropion HCl prolonged release in Italy Mysimba is approved by the European Medicines Agency ..

Perrigo Completes Divestiture Of Tysabri® Royalty Stream For Up To $2.85 Billion

Tuesday, March 28, 2017

Perrigo Company plc a leading global provider of Quality Affordable Healthcare Products today announced it has completed the divestiture of its rights to the royalty stream from global net sales of the multiple sclerosis drug Tysabri natalizumab to RPI Finance Trust an affiliate of Royalty Pharma RP..

Newron Presents Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia

Monday, March 27, 2017

Newron Pharmaceuticals SpA a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system CNS and pain today presented detailed results of a Phase IIa study with its unique sodium channel blocker Evenamide NW3509 in patients with sc..

Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017

Monday, March 27, 2017

Eli Lilly and Company announced plans to invest 850 million in its US operations in 2017 The company39s investments span facilities across its US enterprise including research laboratories manufacturing sites and general and administrative areas The investments are being driven by demand for Lilly p..

CHMP provides positive opinion for EU label update for Novo Nordisk's Tresiba®

Saturday, March 25, 2017

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use CHMP under the European Medicines Agency EMA has issued a positive opinion recommending an update of the label for Tresiba insulin degludec to include data from the SWITCH 1 and 2 clinical trials In the trials Tresi..

ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner

Saturday, March 25, 2017

ShangPharma a leading life science partnering organization providing highquality and costeffective drug development and discovery services technology and investment for the pharmaceutical and biotechnology industry announced today the intent for a strategic corporate restructuring ShangPharma wil..

BioLineRx Announces Acquisition of Agalimmune Ltd.

Friday, March 24, 2017

BioLineRx Ltd a clinicalstage biopharmaceutical company focused on oncology and immunology announced today that it has acquired Agalimmune Ltd a private UKbased company with an innovative anticancer immunotherapy platform Acquisition consideration consisted of a 6 million upfront payment of which 3 ..

C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics

Friday, March 24, 2017

C4 Therapeutics C4T and Calico today announced a fiveyear collaboration to discover develop and commercialize therapies for treating diseases of aging including cancer Under the terms of the agreement the parties will leverage C4Ts expertise and capabilities in targeted protein degradation to joi..

Elbit Imaging Ltd. Announces that an EMA Orphan Drug Designation has been Granted to Gamida Cell

Friday, March 24, 2017

Elbit Imaging Ltd announced that it was informed by Gamida Cell Ltd an indirect associate of the Company that the orphan drug designation which has been granted by the European Medicines Agency39s EMA Committee for Orphan Medicinal Products COMP regarding NiCord has been broadened and now includes a..

TOP